No significant differences were reported in the rates of nausea, diarrhea, dyspepsia, or vomiting, and rates of discontinuation due to AEs were similar between the two groups (6% each)
Findings In New York City, 56.2% of patients prescribed a GLP-1 have a documented type 2 diabetes diagnosis
Enhanced Safety and Efficacy : By accessing WEGOVY or ZEPBOUND through Evernorths pharmacy benefit, patients will benefit from FDA-approved medications and Express Scripts robust safety checks designed to reduce negative or adverse drug interactions
Expression of the CT/CGRP gene and its regulation by dibutyryl cyclic adenosine monophosphate in human osteoblastic cells
Has fewer hormonal effects, reducing the risk of organ enlargement or glucose intolerance
Arterioscler Thromb Vasc Biol 2004